AAAIPodcastLogo

Episode 51: Rhinitis Practice Parameter Update

This is a recorded episode of the AAAAI podcast series, Conversations from the World of Allergy. The host, Dr. David Stukus, interviews Mark Dykewicz, MD FAAAAI about the major topic areas of the 2020 Practice Parameter update for rhinitis. Dr. Dykewicz discusses the rhinitis phenotypes and the parameters to consider for proper diagnosis of rhinitis. Drs. Stukus and Dykewicz explore various treatment options, including general oral and intranasal antihistamines, allergen immunotherapy treatment, and montelukast. Additionally, Dr. Dykewicz shares information about effective combinations of medications for specific symptoms or rhinitis and the use of alternative remedies and treatments.

Target Audience

  • Allergist/immunologists
  • Fellows-in-Training
  • Nurses and Nurse Practitioners
  • Physician Assistants and Other Allied Health Professionals

Learning Objectives

Upon completion of this activity, participants should be able to:

  1. Recognize the various phenotypes of rhinitis  
  2. Identify evidence-based approaches for treatment of a patient with rhinitis 
  3. Choose appropriate elements of a patient’s clinical history and physical exam to properly diagnose rhinitis
Summary
Available credit: 
  • 0.75 Attendance
    Attendance credit.
  • 0.75 CME
    CME credit.
Course opens: 
07/27/2021
Course expires: 
07/26/2022
Cost:
$0.00
Rating: 
0
Planning Committee 

David R. Stukus, MD FAAAAI
Nationwide Children's Hospital, Columbus, OH
Relevant relationships: None

Faculty

Mark S. Dykewicz, MD FAAAAI 
Saint Louis University School of Medicine, St. Louis, MO
Relevant relationships: None

Content Reviewers

Brian C. Schroer, MD FAAAAI
Akron Children's Hospital, Akron, OH
Relevant relationships: None

The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All relevant financial relationships were mitigated by the planners, faculty, and reviewers prior to their participation in the development of this activity.

AAAAI DISCLOSURE POLICY

Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:

  • Employment. Name of employer and job title.
  • Financial interests. All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
  • Research interests. All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
  • Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
  • Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
  • Gifts. All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
  • Other interests. All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.

The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.

ACCREDITATION STATEMENT

The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

DESIGNATION STATEMENT

The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CREDIT CLAIMING PERIOD

Credit claiming for this activity will expire at 11:59 pm on July 26, 2022. Requests to claim credit on or after July 26, 2022 will be subject to an administrative fee.

AAAAI PRIVACY POLICY

To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.

QUESTIONS

Activity related questions should be directed to cme@aaaai.org. 

Available Credit

  • 0.75 Attendance
    Attendance credit.
  • 0.75 CME
    CME credit.

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.  

Internet Explorer is no longer supported.

You must listen to Episode 51: Rhinitis Practice Parameter Update before continuing. Return to this window to continue with the assessment and claim credit.